Labcorp CEO sells 5,903 shares in planned trade

LABCORP HOLDINGS INC.

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. President & CEO Adam H. Schechter sold 5,903 shares of Common Stock in an open-market transaction at a price of $254.50 per share on May 11, 2026. The sale was made pursuant to a pre-established Rule 10b5-1 trading plan.

Following this transaction, Schechter directly holds 107,234 shares of Labcorp Common Stock, indicating he retains a substantial equity position in the company while executing a planned share sale.

Insider Trade Summary 10b5-1

Net Seller: 5,903 shares

Net Sell 1 txn

Insider Schechter Adam H

Role President & CEO

Sold 5,903 shs ($1.50M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,903	$254.50	$1.50M

Holdings After Transaction: Common Stock — 107,234 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Key Figures

Shares sold: 5,903 shares Sale price: $254.50 per share Shares held after sale: 107,234 shares +1 more

4 metrics

Shares sold 5,903 shares Open-market Common Stock sale on May 11, 2026

Sale price $254.50 per share Price for the 5,903 shares sold

Shares held after sale 107,234 shares Direct Common Stock holdings following transaction

Net shares sold 5,903 shares Net-sell direction per transactionSummary

Key Terms

Rule 10b5-1, open-market sale, Common Stock

3 terms

Rule 10b5-1 regulatory

"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open-market sale financial

"transaction_action: open-market sale, transaction_code: S"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: Common Stock in non-derivative transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) report for CEO Adam Schechter?

Labcorp reported that President & CEO Adam H. Schechter sold 5,903 shares of Common Stock. The shares were sold in an open-market transaction at $254.50 per share under a pre-arranged Rule 10b5-1 trading plan.

How many Labcorp (LH) shares did the CEO sell and at what price?

Adam H. Schechter sold 5,903 Labcorp Common Stock shares at $254.50 per share. This was an open-market sale coded “S” on the Form 4 and executed pursuant to a Rule 10b5-1 trading plan.

How many Labcorp (LH) shares does the CEO hold after this Form 4 sale?

After the reported sale, Adam H. Schechter directly holds 107,234 Labcorp Common Stock shares. This post-transaction balance appears on the Form 4 and reflects his remaining direct equity stake following the 5,903-share disposition.

Was the Labcorp (LH) CEO’s share sale made under a Rule 10b5-1 plan?

Yes. A footnote states the transaction was made pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, indicating the sale was pre-scheduled rather than a discretionary, one-off market decision.

What type of transaction is shown in this Labcorp (LH) Form 4 filing?

The Form 4 shows a non-derivative open-market sale of Common Stock, coded “S.” It involves 5,903 shares sold at $254.50 per share, with no derivative exercises or tax-withholding events reported in this filing.

Does the Labcorp (LH) Form 4 show any option exercises or derivative trades?

No. The filing’s derivativeSummary is empty and transaction data reflect only a single non-derivative Common Stock sale. There are no option exercises, conversions, or other derivative security transactions disclosed in this particular Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 09:30 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schechter Adam H

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		S(1)		5,903	D	$254.5	107,234	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Adam H. Schechter	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)